<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To examine whether patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> associated with idiopathic <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> (<z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> [GS]) have specific changes in brain metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We applied proton magnetic resonance spectroscopy (H-MRS) to the anterior cingulate gyrus, insular cortex and thalamus of patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and GS (n = 15) or without GS (n = 15), <z:hpo ids='HP_0000001'>all</z:hpo> diagnosed with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> according to the criteria of the Diagnostic and Statistical Manual of <z:e sem="disease" ids="C0004936" disease_type="Mental or Behavioral Dysfunction" abbrv="">Mental Disorders</z:e>, fourth edition (<z:chebi fb="4" ids="38624">DSM</z:chebi>-IV), and healthy subjects (n = 20) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In the anterior cingulate gyrus, patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and GS showed significant decreases in N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi>-phosphocreatinine (<z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr), <z:chebi fb="3" ids="15354">choline</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi>-phosphocreatinine (Cho/Cr) and <z:chebi fb="0" ids="17268">myoinositol</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi>-phosphocreatinine (ml/Cr) ratios compared with healthy subjects and compared with patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> without GS </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> without GS also showed significant decreases in <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr, Cho/Cr and ml/Cr compared with healthy subjects </plain></SENT>
<SENT sid="4" pm="."><plain>In the insular cortex, patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and GS showed significant decreases in <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr, Cho/Cr and ml/Cr compared with healthy subjects and compared with patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> without GS </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> without GS also showed significant decreases in <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr, Cho/Cr and ml/Cr compared with healthy subjects </plain></SENT>
<SENT sid="6" pm="."><plain>In the thalamus, patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and GS showed significant decreases in <z:chebi fb="8" ids="32918">NAA</z:chebi>/Cr, Cho/Cr and ml/Cr compared with healthy subjects, whereas patients with <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> without GS only showed a significant decrease in ml/Cr compared with healthy subjects </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our findings suggest that brain metabolism is more severely compromised in the subtype of <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> with GS </plain></SENT>
</text></document>